Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass azithromycin administration in children aged 1-59 months in Nigeria
PACTR202603768509836Recruiting
- Sponsor
- Gates Foundation
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of azithromycin in Infectious disease, sponsored by Gates Foundation. Primary endpoints: All-cause under-5 mortality and Azithromycin antimicrobial resistance. Started May 2024; status: recruiting.
02
Drugs
azithromycin
03
Conditions
Infectious disease
Beyond the preview
Go deeper on PACTR202603768509836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202603768509836.